![]() |
市場調查報告書
商品編碼
2032835
生物保存市場報告:按產品類型、應用和地區分類(2026-2034 年)Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2026-2034 |
||||||
2025年全球生物保存市場規模達93億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到218億美元,2026年至2034年的複合年成長率為9.58%。推動市場成長的主要因素包括公眾對個人化醫療日益成長的興趣、研發投入的增加以及對罕見疾病認知和了解的不斷提高。
生物保存是指將細胞、組織、器官或整個生物體等生物材料長期保存在具有活性和功能的狀態。該過程的目標是維持生物材料的完整性、活性和功能,使其能夠被保存、運輸並用於各種用途,包括研究、臨床應用和工業生產。它在醫學、生物技術和研究等各個領域都有廣泛的應用,能夠保存用於移植、再生醫學和藥物研發的細胞、組織和器官。
全球市場的主要驅動力是公眾對個人化醫療日益成長的興趣。此外,各國政府、學術機構和私人組織在生命科學、生技和醫療保健領域加強研發投入,也推動了市場成長。同時,大眾對罕見疾病和遺傳疾病的認知和理解不斷提高,也增加了對保存患者生物檢體的需求。這些技術可支持檢體的採集和保存,有助於闡明疾病機制、開發診斷方法和標靶治療,從而促進全球需求。此外,改進的冷凍保護劑、自動化系統和先進保存方案的開發,拓展了生物保存的功能和應用範圍,進一步提振了市場前景,因為這些技術有助於維持保存生物材料的有效性、可靠性和安全性。
對生物銀行的需求日益成長
生物銀行需求的不斷成長正對全球市場產生重大影響。生物樣本庫是儲存各種生物樣本(包括細胞、組織、血液、DNA和其他生物材料)的設施,用於研究和診斷。這些技術在維持樣本的完整性、活性和功能方面發揮著至關重要的作用,確保了樣本的長期儲存和可用性。大規模人群研究、臨床試驗和研究項目對獲取多樣化且保存完好的生物樣本的需求日益成長,這正在影響全球生物樣本庫市場。此外,隨著精準醫療和個人化醫療保健的日益普及,生物樣本庫提供可用於基因組檢測、生物標記發現和個人化治療方法開發的全面樣本庫的重要性也進一步提升。
再生醫學的持續進步
再生醫學的進步正對全球市場產生重大影響。由於再生醫學旨在利用細胞療法、組織工程和其他創新方法來修復或替換受損組織和器官,因此生物保存——即維持細胞、組織和人工構建體的活性和功能——在再生醫學的成功中發揮著至關重要的作用。此外,這些技術對於在儲存和運輸過程中維持幹細胞的活性和活力也至關重要。冷凍和玻璃化等冷凍保存方法是目前常用的幹細胞保存方法,以備將來用於治療和研究。幹細胞保存方案和冷凍保護劑的進步提高了幹細胞的活性和解凍後的功能,從而促進了市場成長。
生物製藥產業的擴張
生物製藥產業的擴張是影響市場的重要因素。生物製藥產業專注於開發和生產生物製藥,例如治療性蛋白質、抗體、疫苗和細胞療法。生物保存技術在確保這些複雜生物製藥從研發到分銷的整個生命週期中的穩定性、品質和完整性方面發揮著至關重要的作用。由於生物製藥對溫度、光照和濕度等環境條件高度敏感,因此對維持這些藥物在儲存和運輸過程中穩定性和品質的關鍵技術的需求顯著增加。透過採用冷凍保存、冷凍乾燥或其他合適的保存方法,生物製藥公司可以延長產品的保存期限,並確保其在患者用藥時的有效性和安全性。
The global biopreservation market size reached USD 9.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 21.8 Billion by 2034, exhibiting a growth rate (CAGR) of 9.58% during 2026-2034. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.
Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.
The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.
Increasing Demand for Biobanking
The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.
Continual Advancements in Regenerative Medicine
Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.
The Expansion of the Biopharmaceutical Industry
The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.
Biopreservation equipment dominates the market
Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.
On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.
Biobank applications hold the largest share in the market
Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.
On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.
Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.
On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.
Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.